research Clinical Course of Alopecia After COVID-19
A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.
Search
for
Sort by
Research
540-570 / 1000+ results 
research 5-Alpha-Reductase Inhibitors Reduce Remission Time of COVID-19: Results From a Randomized Double-Blind Placebo-Controlled Interventional Trial in 130 SARS-CoV-2 Positive Men
5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.
research Protective Trend of Anti-Androgen Therapy During the COVID-19 Pandemic: A Meta-Analysis
Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.
research Androgenetic Alopecia in Women and Men Is Not Related to COVID-19 Infection Severity: A Prospective Cohort Study of Hospitalized COVID-19 Patients
Hair loss doesn't affect COVID-19 severity.
research Tofacitinib Treatment in Patients With Active COVID-19 Infection
Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.
research Trend and Co-occurrence Network of COVID-19 Symptoms From Large-Scale Social Media Data: Infoveillance Study
Social media data can help track COVID-19 symptoms and predict the pandemic's status.
research The Effects of Changing Lifestyle and Daily Behaviors in the First Months of COVID-19 Outbreak on Dermatological Diseases: Retrospective Cross-Sectional Observational Study
Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.
research Comment on 'Androgens and Women: COVID-19 Outcomes in Women with Acne Vulgaris, Polycystic Ovarian Syndrome, and Hirsutism'
Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.
research Letter to the Editor on COVID-19 Infection in Men on Testosterone Replacement Therapy
The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.
research Global Epidemiology of Telogen Effluvium After COVID-19 Pandemic: A Systematic Review and Modeling Study
research The Gabrin Sign's Potential for Identifying High-Risk Patients for COVID-19 With Androgenic Alopecia
The Gabrin sign may help identify COVID-19 patients at high risk who also have hair loss due to male hormones.
research Mucocutaneous Presentations of Critical and Non-Critical Admitted COVID-19 Patients and Vaccine-Associated Dermatoses: A Study from Iran
The study found that skin conditions in COVID-19 patients can signal serious internal organ damage and may be life-threatening.
research The Role of Neurorehabilitation in Post-COVID-19 Syndrome
Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.
research Humoral Immune Response to COVID-19 Vaccination in Psoriasis Patients on Biologic Therapy Is Impaired Compared to Healthy Controls
Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.
research Prevalence and Characterization of Long Covid-19 Symptoms in Health Care Professionals: A Need of the Hour
Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.
research Symptom Profile of Patients With Post-Covid-19 Conditions and Influencing Factors for Recovery
Zinc acetate hydrate may help reduce fatigue and hair loss in post-COVID-19 patients.
research Trend and Co-Occurrence Network of COVID-19 Symptoms From Large-Scale Social Media Data: Infoveillance Study
Social media data can help track and predict COVID-19 symptoms and trends.
research Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.
research Evidence Regarding the Use of the Monoclonal Antibody Tocilizumab as a Therapy for COVID-19
Tocilizumab might be an effective treatment for COVID-19.
research Blood Group O and Post-COVID-19 Syndrome
People with blood group O may have a higher risk of developing post-COVID-19 syndrome.
research Another Year in the Grip of COVID-19 with Slow Recovery
2021 saw a slow return to normalcy and increased scientific engagement despite COVID-19 challenges.
research Immune System Response to the COVID-19 Virus and Third Boosters
Third booster shots enhance the immune system's response to the COVID-19 virus.
research Cutaneous T-Cell Lymphoma Outcomes During COVID-19
CTCL patients can safely continue treatment during COVID-19 with proper safety measures.
research Delivering Care for the Underserved During COVID-19 Through Real-Time Teledermatology: A Cross-Sectional Review of Patients at a Student-Run Free Clinic in Dallas
The study evaluated how alopecia areata severity relates to its psychosocial effects on patients.
research A Rare Case of Constrictive Pericarditis with Co-Existing Positive COVID-19: Probable Autoimmune or Immunoglobulin Related Disease
An 80-year-old man with COVID-19 also had constrictive pericarditis, possibly due to an autoimmune or immunoglobulin related disease, and improved after surgery.
research Study of Pediatric Dermatology Consultations During COVID-19 Lockdown
Most child skin problems during the COVID-19 lockdown were not emergencies and could have been handled by teleconsultation.
research Use of Finasteride and Spironolactone in Hospitalized COVID-19 Patients and Their Effect on Severity Outcomes
research Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study
Women are more likely to have long-term post-COVID symptoms than men.
research Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial
Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.
research Discovery of Clinically Approved Drugs Capable of Inhibiting SARS-CoV-2 In Vitro Infection Using a Phenotypic Screening Strategy and Network-Analysis to Predict Their Potential to Treat COVID-19
Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.